Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Government Contract opportunity from Department Of Veterans Affairs was posted on June 1, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Manufacturing of Fluorouracil 5% Cream (Topical)

Closed
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The contract involves the full-scale manufacturing of Fluorouracil 5% Cream, a topical medication, encompassing all stages from formulation to quality control, batch testing, and ensuring regulatory compliance. This production is intended for distribution to government agencies, specifically the Department of Veterans Affairs through Nac Pharmaceuticals. The scope includes maintaining high standards in manufacturing processes to meet both therapeutic efficacy and safety standards as mandated by regulatory authorities. Issued as a subcontract with no specified set-aside, the contract falls under the NAICS code 325412, relating to pharmaceutical preparation manufacturing. The solicitation was posted on June 1, 2026, with a response deadline set for June 22, 2026. While specific geographic details for the place of performance and agency contact information are not provided, the contract is designed to support government healthcare needs by supplying a vital topical chemotherapy cream, maximizing availability through government channels.

General Info

Manufacture and supply Fluorouracil 5% Cream to Department of Veterans Affairs, ensuring compliance.

Agency

Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)View Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

IL

Set-Aside

NONE

Documents

This scope was carved out of 36E79726R0024.

The full solicitation package (3 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

6505--Fluorouracil RFP

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed
Posted

subcontract

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Veterans Affairs → Nac Pharmaceuticals (36E797)
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Full-scale manufacturing of Fluorouracil 5% Cream including formulation, quality control, batch testing, and regulatory compliance for government distribution.

More opportunities from Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

Same awarding agency

NAICS: 325412
New
Federal
6505--Ticagrelor Tablets
Solicitation # 36E79726R0028
The Department of Veterans Affairs National Acquisition Center is seeking an unrestricted procurement to establish an uninterrupted source of supply for Ticagrelor Tablets. This firm-fixed-price, indefinite-delivery requirements contract supports multiple federal health agencies, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The award is designated as a HUBZONE small business set-aside and will be granted to the lowest-priced, technically acceptable offeror. The contract structure consists of a base year and four one-year options, with a maximum 60-calendar day implementation period before the ordering period begins. The scope of work includes the supply of Ticagrelor in 60mg and 90mg strengths across various bottle sizes, ranging from 60 to 1,000 tablets. Strict packaging and labeling standards are required, including the use of cylindrical bottles with a minimum 120cc volume and 5.75 inch circumference, safety caps that are convertible or deshelled, and unique 11-digit NDC numbers. All products must be compatible with automated dispensing units and feature GS1-128 or HIBC linear bar codes, as well as two-dimensional data matrix bar codes per the Drug Supply Chain Security Act. To be eligible for award, offerors must maintain an acceptable FDA cGMP status for their manufacturing facilities and provide the necessary NDA, ANDA, or BLA clearances. Those who are not the manufacturer must provide a formal Letter of Commitment ensuring a sufficient source of supply. Distribution will be managed through Government Prime Vendor contracts, with deliveries made to approximately 56 VA and DoD distribution centers nationwide. Proposals must be submitted in PDF or Word format, including a signed SF-1449 and pricing for all line items across the base and option years, with prices held firm for 120 calendar days.
Pharmaceutical Preparation Manufacturing

POSTED

3 days ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
Federal
6505--2027-2028 Influenza Virus Vaccine
Solicitation # 36E79726R0035
Solicitation 36E79726R0035 is an unrestricted FAR Part 12 commercial-item procurement issued by the Department of Veterans Affairs National Acquisition Center for the supply of Influenza Virus Vaccines for the 2027-2028 season. The contract requires the delivery of trivalent or quadrivalent vaccines in pre-filled single-dose syringes with plunger and Luer lock needle attachments, provided in boxes of 10. The vaccines must be latex and preservative free, with specific FDA approval and labeling required for pediatric populations (6 to 35 months) and seniors (65 years and older). Final vaccine presentation is based on World Health Organization recommendations, with a preference for Trivalent presentations if both Trivalent and Quadrivalent options are commercially available. The award will be made on a per solicitation line item basis for the VA, Bureau of Prisons, Indian Health Service, and the Captain James A. Lovell Federal Health Care Center. Deliveries are Free On Board Destination to government facilities across the United States, Puerto Rico, and the Philippines. Most facilities require a two-part delivery schedule, with at least 50 percent of the order delivered between August 15 and September 15, 2027, and the remainder by October 15, 2027; however, the FHCC must receive 100 percent of its awarded quantity by September 15, 2027. Offerors must provide the full quantity for any line item bid, and final pricing must include the Cost Recovery Fee and Federal Excise Tax.
Pharmaceutical Preparation Manufacturing

POSTED

4 days ago

DEADLINE

in 11 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS